0D53.LSE Financiere de Tubize SA

Healthcare Pharmaceuticals London Exchange
203.83 EUR
Close of Nov 3, 2026
169.70 249.55
Market cap
EUR 9.08B
P/E
26.8x
P/B
-
ROE
9.5%
Dividend yield
0.38%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Jun 2019.

Is 0D53.LSE undervalued?

Graham number

The Graham number of Financiere de Tubize SA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Financiere de Tubize SA fundamental analysis

No fundamental analysis for Financiere de Tubize SA yet.

Financiere de Tubize SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Financiere de Tubize SA

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

Full company profile